Effect of Treatment With Insulin VIAjectTM Compared to Regular Human Insulin and Insulin Lispro on Mealtime Blood Vessel Stress in Patients With Type 2 Diabetes Mellitus.

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions

Type 2 Diabetes

Interventions

DRUG

Regular Human Insulin

0.10 U/Kg- 15 minutes before ingestion of a standardized liquid meal.

DRUG

Insulin Lispro

90% of Regular Human Insulin dose administer immediately before ingestion of a standardized liquid meal.

DRUG

Insulin VIAject™ (75%)

75 % of Regular Human Insulin dose administer immediately before ingestion of a standardized liquid meal

DRUG

Insulin VIAject™ (90%)

90 % of Regular Human Insulin dose administer immediately before ingestion of a standardized liquid meal

Trial Locations (1)

IKFE, Parcusstrasse 8